Medical Financial Statements From 2010 to 2026
| MJNA Stock | USD 0.0002 0.0001 33.33% |
Check Medical Marijuana financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medical Marijuana's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medical financial statements analysis is a perfect complement when working with Medical Marijuana Valuation or Volatility modules.
Medical |
Medical Marijuana I Company Return On Asset Analysis
Medical Marijuana's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medical Marijuana Return On Asset | -0.0146 |
Most of Medical Marijuana's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medical Marijuana I is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medical Marijuana I has a Return On Asset of -0.0146. This is 99.83% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is 89.57% lower than that of the firm.
Medical Marijuana Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medical Marijuana's current stock value. Our valuation model uses many indicators to compare Medical Marijuana value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medical Marijuana competition to find correlations between indicators driving Medical Marijuana's intrinsic value. More Info.Medical Marijuana I is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medical Marijuana by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medical Marijuana's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Medical Marijuana Financial Statements
Medical Marijuana stakeholders use historical fundamental indicators, such as Medical Marijuana's revenue or net income, to determine how well the company is positioned to perform in the future. Although Medical Marijuana investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medical Marijuana's assets and liabilities are reflected in the revenues and expenses on Medical Marijuana's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medical Marijuana I. Please read more on our technical analysis and fundamental analysis pages.
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. Medical Marijuana, Inc. was incorporated in 2005 and is based in San Diego, California. Medical Marijuana operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 91 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Medical Pink Sheet
Medical Marijuana financial ratios help investors to determine whether Medical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medical with respect to the benefits of owning Medical Marijuana security.